Abingdon Health (LON:ABDX) Stock Price Down 0.5% – Here’s Why

Abingdon Health Plc (LON:ABDXGet Free Report) shares dropped 0.5% during trading on Thursday . The stock traded as low as GBX 10.50 and last traded at GBX 10.69. Approximately 57,255 shares were traded during trading, a decline of 77% from the average daily volume of 250,836 shares. The stock had previously closed at GBX 10.75.

Abingdon Health Trading Down 0.5%

The company has a fifty day simple moving average of GBX 10.37 and a two-hundred day simple moving average of GBX 9.67. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05. The company has a market cap of £26.84 million, a PE ratio of -13.20 and a beta of 0.13.

Abingdon Health Company Profile

(Get Free Report)

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.

See Also

Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.